Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

NHS Commissioning Board

ABPI London offices

Half of England’s adults say NHS spends too little on drugs

Medicines account for 10p of every £1 spent by NHS, says ABPI

National Institute for Health and Care Excellence NICE logo

NICE denies two drugs in new MS guidance

Sativex and Fampyra too costly for NHS in England

Turkey’s pharma market is ripe for profitability

But will the highly efficient market be hindered by the government price referencing system?

- PMLiVE

NICE recommends Lundbeck’s alcohol dependency drug

NHS patients to have access to Selincro to help control drinking

- PMLiVE

Janssen backs NHS diabetes challenge

Will provide £200,000 to spread innovation across UK

- PMLiVE

The price is right: drug reimbursement in Europe

EFPIA's director general argues that drug pricing is not a gameshow

- PMLiVE

Awards recognise hepatitis C care in UK

First QiC Hepatitis C takes place at BASL conference

- PMLiVE

Novartis expands eyecare partnership with NHS

And wins new licence for Lucentis

National Institute for Health and Care Excellence NICE logo

Remicade, Humira and Simponi face NICE knock-back

Draft guidance does not recommend the drugs for ulcerative colitis

- PMLiVE

Doctors.net.uk expands online educational resources

Online physicians network adds to existing material to aid medical training

- PMLiVE

NHS launches MyNHS transparency site

Allows public to view performance data and shape services

- PMLiVE

Brain tumour vaccine is UK’s first ‘Promising Innovative Medicine’

Northwest Biotherapeutics’ DCVax-L gets UK version of ‘breakthrough’ status for use in cancer

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links